Latest filing published 29 Aug 2025 for iTeos Therapeutics, Inc..
No signal scores available.
David Feltquate discloses dealings in iTeos Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 6 December 2024 to 29 August 2025, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 29 August 2025, reports a transaction in iTeos Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations